PERL Grant

Our Team

is composed by young Nuclear Medicine physicians, Haematologists
and Radiotherapists

Doctors With Vision

The PERL team

Young Nuclear Medicine physicians, Hematologists and Radiotherapists


The project PI

MD, PhD, Nuclear Medicine physician, head of TracerGLab GSTeP

Dr. Salvatore Annunziata

won a national grant on lymphoma PET radiomics and works on new PET tracers in several diseases at TracerGLab.

  • View Profile
MD, PhD, Nuclear Physician PERL co-PI, TracerGLab GSTeP, Direzione Scientifica IRCCS

Dr. Angela Collarino

works in Direzione Scientifica and with an international network on nuclear imaging in female cancer

  • View Profile
MD, Nuclear Physician, PERL fellow, TracerGLab GSTeP

Dr. Elizabeth Triumbari

is a fellow within the grant on lymphoma PET, with international experience on new digital #PET

  • View Profile
MD, PhD, Radiotherapist, Head of Radiomics GSTeP

Dr. Luca Boldrini

with national and international experience in radiomics with different imaging tools

  • View Profile


The PERL team is composed by young Nuclear Medicine physicians, Haematologists and Radiotherapists, with national and international experience on clinical and research activities on PET/CT in lymphoma. The project PI is Salvatore Annunziata, MD, PhD, Nuclear Medicine physician and head of TracerGLab GSTeP, an institutional research facility dedicated to PET/CT radiopharmaceuticals. During the project, other personnel will be involved such as a dedicated fellow in TracerGLab GSTeP and a data analyst in Radiomics GSTeP.



Our Vision

What are we doing

No studies have been published on the prognostic role of radiomic features derived from baseline 18F-FDG-PET/CT in a large cohort of high-grade lymphoma.

This project aims to gap this knowledge, studying a large dataset of patients in our referral university hospital by an experienced multidisciplinary team. The retrospective nature of this project enables to

collect a large dataset of patients with lymphoma with a long-term follow-up, useful to evaluate the prognostic power of volumetric and radiomic features using the conventional reference standards in lymphoma.


PERL is a the largest monocentric research project on 18F-FDG
Positron Emission Radiomics in Lymphoma


Follow us on

Quick Links

  • HOME

Contact Info

  • Address

    Largo Francesco Vito,1 - 00168 Roma RM

  • Mail
Scroll to Top